Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/ZYDUS-LIFESCIENCES-LIMITE-34067618/news/Cadila-Healthcare-Zydus-Cadila-receives-tentative-approval-from-the-USFDA-for-Ibrutinib-Tablets-35907588/?utm_source=whatsapp&utm_medium=social&utm_campaign=share